Supplements

Melatonin

Evidence: strong_human

Mechanism of Action

Melatonin (N-acetyl-5-methoxytryptamine) is synthesized from serotonin in the pineal gland, regulated by the suprachiasmatic nucleus (SCN) via the retinohypothalamic tract. It binds MT1 and MT2 G-protein coupled receptors: MT1 activation suppresses neuronal firing in the SCN (sleep onset), while MT2 modulates circadian phase shifting. Beyond sleep, melatonin is a potent antioxidant that scavenges hydroxyl radicals, peroxynitrite, and singlet oxygen, and upregulates antioxidant enzymes (GPx, SOD, catalase) via Nrf2. It has anti-inflammatory properties (NF-kB suppression), immunomodulatory effects, oncostatic activity (anti-proliferative in several cancer types), and mitochondrial protective functions.

Dosing Protocol

Standard: 0.3-1mg for sleep onset (physiological); 3-5mg for jet lag; 10-20mg for oncological adjunct (under supervision)

Maintenance: 0.3-1mg for sleep (most people overdose; physiological replacement is 0.3mg)

Administration: oralsublingual

Timing: 30-60 minutes before desired sleep onset. For circadian phase advance: 4-6 hours before desired bedtime. Sublingual for faster onset. Dim lights 1-2 hours before taking.

Duration: Short-term for jet lag (3-5 days); ongoing at low dose for circadian support if needed; extended for oncological use under supervision

Notes

THE DOSE MYTH: Most people take 3-10mg, but physiological replacement dose is 0.3mg. MIT research showed 0.3mg is optimal for sleep onset without morning grogginess or receptor desensitization. Higher doses (3-5mg) are appropriate for jet lag and circadian resetting. The oncological dose (10-20mg+) is a different clinical application with separate evidence base. MTNR1B gene variants (rs10830963) affect glucose metabolism response to melatonin — clients with this variant may experience impaired glucose tolerance with evening melatonin. Always start with 0.3mg and titrate up. Address sleep hygiene before supplementation.

Stacking

  • Magnesium Glycinate
  • L-Theanine
  • Glycine
  • Tart Cherry Extract

Interactions

  • Benzodiazepines/sedatives [MEDIUM] — Additive sedation
  • Fluvoxamine (SSRI) [HIGH] — Fluvoxamine inhibits CYP1A2, massively increasing melatonin levels (up to 12-fold)
  • Immunosuppressants [MEDIUM] — Melatonin is immunostimulatory — may oppose immunosuppression
  • Anticoagulants [LOW] — Melatonin may have mild anticoagulant effects
  • Diabetes medications [LOW] — Melatonin may affect insulin sensitivity (MTNR1B receptor variant-dependent)

Contraindications

  • Autoimmune conditions (immunostimulatory)
  • Depression (may worsen in some individuals)
  • Seizure disorders (mixed data)
  • Pregnancy/lactation

Side Effects

  • Morning grogginess (dose too high)
  • Vivid dreams/nightmares
  • Headache
  • Nausea
  • Dizziness
  • Reduced libido (at high chronic doses)
  • Next-day drowsiness
  • Depression (rare)

Key Papers

  • 10.1371/journal.pone.0063773
  • 10.1016/j.sleep.2004.10.007
  • 10.1016/j.molcel.2018.11.020

Source Quality

Pharmaceutical-grade melatonin, USP verified. Low-dose formulations (0.3-1mg) are difficult to find — most products are 3-10mg (supraphysiological). Sublingual or liquid formulations allow precise low-dose titration. Extended-release for sleep maintenance (vs immediate-release for sleep onset). Brands: Life Extension (0.3mg available), NOW Melatonin (liquid for dose titration), Natrol.

Disclaimer: This information is for educational purposes only and is not medical advice. BioAccelera Labs does not diagnose, treat, or prescribe. Consult a licensed healthcare provider before using any compound.

Should Melatonin Be in Your Stack?

Take the free assessment and get personalized recommendations based on your biology and goals.

Get Your Free Protocolor take the assessment →
← Browse All 231 Compounds